COVID-19 vaccine hesitancy in Addis Ababa, Ethiopia: a mixed-method study.
COVID-19
Hesitancy
Vaccine
attitude
knowledge
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
30 05 2022
30 05 2022
Historique:
entrez:
31
5
2022
pubmed:
1
6
2022
medline:
3
6
2022
Statut:
epublish
Résumé
Data on COVID-19 vaccine hesitancy is limited in Ethiopia and other parts of Africa. Therefore, the aim of this study was to determine the level of COVID-19 vaccine hesitancy and its associated factors in Addis Ababa, Ethiopia. A community-based concurrent mixed-method study. In a community setting. Adult residents (n=422) of Akaki Kality subcity who were recruited by a two stage sampling technique and 24 adults who were selected purposively were included for the quantitative and qualitative part of the study respectively. Data were collected by face-to-face interview using a semistructured questionnaire. Factors associated with COVID-19 vaccine hesitancy were identified by multivariable binary logistic regression model. One out five (19.1%, 95% CI 15.3% to 24.6%) participants were not willing to get vaccinated. In the multivariable analysis, vaccine hesitancy was significantly associated with being female (aOR=1.97; 95% CI 1.10 to 3.89), having negative attitude towards COVID-19 and its preventive measures (aOR=1.75; 95% CI 1.08 to 3.02), and primary information source being social media (internet) (aOR=3.59; 95% CI 1.75 to 7.37). Study participants have predominantly stated that they did not have enough information about the vaccine, feared it would not be effective or have too many side effects, and reflected their uncertainty towards the quality of the vaccine. A considerable proportion of the people in Addis Ababa have concerns on COVID-19 vaccines and unwilling to accept them. This was due to the misconceptions, negative attitudes and use of social media as their primary source of information. Providing the community with health education and consistent efforts to enhance the prevention measures are important, particularly using different medias including social media.
Identifiants
pubmed: 35636790
pii: bmjopen-2021-052432
doi: 10.1136/bmjopen-2021-052432
pmc: PMC9152622
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e052432Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Vaccine. 2020 Dec 3;38(51):8090-8098
pubmed: 33187765
Psychol Med. 2020 Oct 19;:1-3
pubmed: 33070804
N Engl J Med. 2020 Apr 30;382(18):e41
pubmed: 32212516
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
Risk Manag Healthc Policy. 2021 Jan 22;14:253-262
pubmed: 33519250
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
PLoS One. 2020 May 21;15(5):e0233668
pubmed: 32437434
Am J Trop Med Hyg. 2020 Dec;103(6):2357-2367
pubmed: 33124537
Pan Afr Med J. 2020 Jun 16;35(Suppl 2):79
pubmed: 33623603
Vaccines (Basel). 2020 Oct 01;8(4):
pubmed: 33019663
BMJ Open. 2020 Nov 14;10(11):e044202
pubmed: 33191269
Risk Manag Healthc Policy. 2020 Dec 03;13:2803-2810
pubmed: 33299368
Psychol Med. 2021 Jul;51(10):1763-1769
pubmed: 32513320
J Community Health. 2021 Jun;46(3):457-470
pubmed: 32638198
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
Vaccines (Basel). 2020 Oct 03;8(4):
pubmed: 33022917
Curr Med Res Opin. 2020 Dec;36(12):1955-1960
pubmed: 33044091